Publications in collaboration with researchers from Royal Hallamshire Hospital (3)

2013

  1. Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial

    European Urology, Vol. 63, Núm. 2, pp. 283-295

2004

  1. Administration of nitric oxide synthase inhibitor 546C88 in septic shock [1] (multiple letters)

    Critical Care Medicine

  2. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock

    Critical Care Medicine, Vol. 32, Núm. 1, pp. 21-30